Latest News in the pharma Industry

Research & Development

Regeneron’s Eylea Injection for the treatment of visual impairment secondary to myopic CNV gains EU approval

Regeneron’s Eylea Injection for the treatment of visual impairment secondary to myopic CNV gains EU approval

1 Nov 2015

Eyela already approved in the EU for neovasular (wet) age-related macular degeneration.

Read more 
BMS receives approval from FDA for Yervoy (ipilimumab) as adjuvant treatment for fully resected Stage III melanoma

BMS receives approval from FDA for Yervoy (ipilimumab) as adjuvant treatment for fully resected Stage III melanoma

29 Oct 2015

First company to demonstrate the potential of an immune checkpoint inhibitor in the adjuvant treatment for these patients.

Read more 
Ashland presents science-based strategy to enhance pharmaceutical formulation quality and advance drug delivery

Ashland presents science-based strategy to enhance pharmaceutical formulation quality and advance drug delivery

29 Oct 2015

A scientific approach to select polymer excipients that will better serve the pharmaceutical industry.

Read more 
Shire's OPUS-3 Phase II trial with lifitegrast meets primary and key secondary endpoints, significantly reducing patient-reported symptoms for dry eye disease

Shire's OPUS-3 Phase II trial with lifitegrast meets primary and key secondary endpoints, significantly reducing patient-reported symptoms for dry eye disease

29 Oct 2015

Data to support lifitegrast FDA resubmission in Q1 2016; plans on track for potential 2016 launch.

Read more 
Affinivax to collaboration with ClearPath and Astellas to develop vaccines to prevent nosocomial infections

Affinivax to collaboration with ClearPath and Astellas to develop vaccines to prevent nosocomial infections

28 Oct 2015

Collaboration will utilize Affinivax’s novel MAPS Vaccine Technology Platform.

Read more 
Agilent Technologies introduces industry’s most sensitive GC/MSD system

Agilent Technologies introduces industry’s most sensitive GC/MSD system

27 Oct 2015

Pollutants and contaminants can now be detected at previously undetectable levels.

Read more 
BioGenes launches enhanced generic E.coli host cell protein assay for biomanufacturing

BioGenes launches enhanced generic E.coli host cell protein assay for biomanufacturing

27 Oct 2015

The E.coli|360-HCP ELISA allows sponsors and biotech companies to postpone the development of a cost-intensive specific HCP assay until a more informed decision on the success of a biologic in development can be made.

Read more 
Amgen receives CHMP positive opinion for Imlygic

Amgen receives CHMP positive opinion for Imlygic

25 Oct 2015

If approved by the European Commission, Imlygic would be the first in a class of novel agents known as oncolytic immunotherapies.

Read more 
Lilly and AstraZeneca expand immuno-oncology research collaboration with new combinations

Lilly and AstraZeneca expand immuno-oncology research collaboration with new combinations

23 Oct 2015

AstraZeneca's anti-PD-L1 immune checkpoint inhibitor, durvalumab (MEDI4736), will be combined with Lilly molecules that target the immune system.

Read more 
Novartis receives positive CHMP opinion for the first IL-17A inhibitor Cosentyx to treat ankylosing spondylitis and psoriatic arthritis

Novartis receives positive CHMP opinion for the first IL-17A inhibitor Cosentyx to treat ankylosing spondylitis and psoriatic arthritis

23 Oct 2015

Cosentyx demonstrated rapid onset of action and long-term sustainability in patients with and without prior treatment using anti-tumour-necrosis-factor (anti-TNF) therapy.

Read more 
Metrion Biosciences becomes independent CRO

Metrion Biosciences becomes independent CRO

22 Oct 2015

Management team completes buy out of specialist ion channel research business from Xention.

Read more 
Impax receives FDA approval for generic version of Intuniv (guanfacine)

Impax receives FDA approval for generic version of Intuniv (guanfacine)

22 Oct 2015

Third generic product approved since the resolution of the warning letter at the Hayward facility.

Read more